• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Psoriasis and Cardiovascular Disease: Lesion Beyond the Skin.银屑病与心血管疾病：皮肤之外的损害
Arq Bras Cardiol. 2019 Sep 2;113(2):250-251. doi: 10.5935/abc.20190153.
2
Cardiovascular risk and psoriasis: beyond the traditional risk factors.心血管风险与银屑病：超越传统危险因素。
Am J Med. 2014 Jan;127(1):12-8. doi: 10.1016/j.amjmed.2013.08.013. Epub 2013 Oct 23.
3
[Psoriasis and cardio-vascular disorders].[银屑病与心血管疾病]
Przegl Lek. 2002;59(10):844-7.
4
[Psoriasis and cardiovascular risk factors].[银屑病与心血管危险因素]
Harefuah. 2012 Oct;151(10):573-5, 605.
5
The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.银屑病之痛：银屑病患者心血管风险综述
Cardiol Rev. 2015 Nov-Dec;23(6):312-6. doi: 10.1097/CRD.0000000000000048.
6
Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.银屑病合并的心血管和代谢性疾病：超越皮肤范畴
Intern Med. 2017;56(13):1613-1619. doi: 10.2169/internalmedicine.56.8209. Epub 2017 Jul 1.
7
Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices.银屑病与心血管风险：银屑病与心血管功能指标之间的相关性
Angiology. 2018 Jan;69(1):31-37. doi: 10.1177/0003319717699329. Epub 2017 Mar 21.
8
Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors.炎症性皮肤病中的共病。银屑病、化脓性汗腺炎与心血管危险因素。
Dan Med J. 2015 Sep;62(9).
9
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.糖化白蛋白是银屑病炎症和亚临床心血管疾病的新型生物标志物。
Circ Res. 2016 Nov 11;119(11):1242-1253. doi: 10.1161/CIRCRESAHA.116.309637. Epub 2016 Sep 21.
10
Psoriasis strikes back! Epicardial adipose tissue: another contributor to the higher cardiovascular risk in psoriasis.银屑病反击！心外膜脂肪组织：银屑病心血管风险升高的另一个因素。
Rev Port Cardiol. 2015 Oct;34(10):613-6. doi: 10.1016/j.repc.2015.04.007. Epub 2015 Sep 26.

引用本文的文献

1
Could SCUBE-1 be a marker for subclinical atherosclerosis other than carotid artery intima-media thickness in patients with psoriasis?SCUBE-1 是否可作为银屑病患者除颈动脉内膜中层厚度以外的亚临床动脉粥样硬化的标志物？
An Bras Dermatol. 2023 Sep-Oct;98(5):595-601. doi: 10.1016/j.abd.2022.08.012. Epub 2023 May 15.

本文引用的文献

1
Cardiovascular Risk in Psoriasis Patients: Clinical, Functional and Morphological Parameters.银屑病患者的心血管风险：临床、功能和形态参数。
Arq Bras Cardiol. 2019 Jul 18;113(2):242-249. doi: 10.5935/abc.20190123.
2
Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review.靶向动脉粥样硬化中的免疫系统：美国心脏病学会最新综述。
J Am Coll Cardiol. 2019 Apr 9;73(13):1691-1706. doi: 10.1016/j.jacc.2018.12.083.
3
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.联合 AAD-NPF 指南：关注并重视共病，以管理和治疗银屑病。
J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. doi: 10.1016/j.jaad.2018.11.058. Epub 2019 Feb 13.
4
Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.肿瘤坏死因子抑制剂治疗与银屑病患者亚临床动脉粥样硬化指数降低相关。
Arthritis Rheumatol. 2018 Mar;70(3):408-416. doi: 10.1002/art.40366. Epub 2018 Feb 6.
5
Psoriasis and Cardiovascular Risk-Do Promising New Biomarkers Have Clinical Impact?银屑病与心血管风险——有前途的新型生物标志物是否具有临床影响？
Mediators Inflamm. 2017;2017:7279818. doi: 10.1155/2017/7279818. Epub 2017 Aug 29.
6
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
7
Risk of Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis: A Nationwide Cohort Study.银屑病和银屑病关节炎患者心肌梗死风险：一项全国性队列研究
Acta Derm Venereol. 2017 Jul 6;97(7):819-824. doi: 10.2340/00015555-2657.
8
Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.类风湿关节炎、银屑病或银屑病关节炎患者心血管危险因素的发病率和患病率
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1510-1518. doi: 10.1002/acr.23171. Epub 2017 Sep 7.
9
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.EULAR 建议：类风湿关节炎和其他形式的炎性关节病患者的心血管疾病风险管理：2015/2016 更新。
Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3.
10
GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.糖化白蛋白是银屑病炎症和亚临床心血管疾病的新型生物标志物。
Circ Res. 2016 Nov 11;119(11):1242-1253. doi: 10.1161/CIRCRESAHA.116.309637. Epub 2016 Sep 21.

Psoriasis and Cardiovascular Disease: Lesion Beyond the Skin.

作者信息

Bacchiega Bruno Cesar

机构信息

Hospital de Câncer de Barretos, Barretos, SP - Brazil.

Santa Casa de Misericórdia de Barretos, Barretos, SP - Brazil.

出版信息

Arq Bras Cardiol. 2019 Sep 2;113(2):250-251. doi: 10.5935/abc.20190153.

DOI:10.5935/abc.20190153
PMID:31483020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6777876/
Abstract
摘要